M&A

1. K1Deferred revenue is a liability representing cash already collected for goods or services not yet delivered.
2. K2Historically, the buyer wrote acquired deferred revenue down to fair value — approximately the cost to perform plus a small profit margin.
3. K3Under the old fair-value treatment, less revenue was recognized after close because the liability covered only cost plus margin, not the full contract value.
4. K4The old write-down reduced the acquired deferred revenue balance on the opening balance sheet, and that reduction increased the amount allocated to goodwill.
5. K5The old fair-value approach changed under ASU 2021-08 because it frequently contradicted ASC 606.
6. K6The old fair-value approach made combined-company revenue hard to predict.
7. K7Under ASU 2021-08, contract liabilities are no longer written down — they carry over at the target's book value.
8. K8Revenue is recognized under the same ASC 606 principles the target already applied, flowing exactly as it would have on a standalone basis.
9. K9Under ASU 2021-08, no purchase accounting adjustment touches goodwill.

R1K2→K3causesTest it

Writing the liability down to cost plus margin directly causes less post-close revenue to be recognized.

R2K2→K4causesTest it

Reducing the acquired deferred revenue liability forces more of the purchase price into goodwill.

R3K3↔K4confused withTest it

Learners conflate less revenue recognized after close with the opening balance sheet liability reduction and goodwill effect.

R4K5→K6causesTest it

The conflict with ASC 606 under the old approach is what made combined-company revenue hard to predict.

R5K5→K7causesTest it

The ASC 606 conflict under the old approach is precisely why ASU 2021-08 eliminated the write-down.

R6K7→K8requiresTest it

No write-down means the target's liability carries over, so post-close recognition must follow ASC 606 as standalone.

R7K7→K9causesTest it

Carrying contract liabilities at book value means no purchase accounting adjustment hits goodwill.

1. K1In a stock purchase the buyer acquires the whole company including all assets and liabilities, with no ability to choose
2. K2In an asset purchase the buyer can choose which assets and liabilities to acquire, which generally leads to a higher price
3. K3Stock purchase is best for the seller because the buyer cannot step up assets for tax savings; asset purchase is best for the buyer because written-up assets generate tax-deductible depreciation while the seller pays increased taxes
4. K4Asset purchases are typically used when the seller is distressed, and NOLs are not carried forward in an asset purchase
5. K5A 338(h)(10) election treats the deal as a stock purchase for the seller but as an asset purchase for the buyer, giving the buyer depreciation from the write-up (at the cost of double taxation for the seller)

No relations on this card. That is a real finding rather than a gap when the points are parallel — an enumeration has nothing to derive from anything else.

1. K1Break-even synergies are the amount of synergies a deal must deliver for the combined company's EPS to exactly equal the buyer's standalone EPS — the point where the deal is neither accretive nor dilutive.
2. K2They are useful as a sanity check.
3. K3If the break-even number exceeds realistic synergy estimates, the deal's accretion depends on synergies you probably won't get.
4. K4The break-even synergy calculation works in two steps.
5. K5First, build pro forma EPS with zero synergies: combine the two companies' net incomes, then subtract the after-tax interest expense on any new debt raised and the after-tax interest income given up on cash used to fund the deal.
6. K6Divide that zero-synergy net income by the pro forma share count, which includes any new shares issued to the seller.
7. K7If that zero-synergy pro forma EPS falls below the buyer's standalone EPS, multiply the per-share shortfall by the pro forma share count to get the after-tax synergies needed to close the gap.
8. K8Then divide that after-tax shortfall by one minus the tax rate to gross it up to the pre-tax figure, which is break-even synergies — the number to compare against your synergy case.

R1K1→K2causesTest it

Only because break-even synergies mark the neither-accretive-nor-dilutive point does it function as a sanity-check benchmark rather than a projection.

R2K3→K1requiresTest it

The realism check only bites against the zero-accretion threshold that the break-even synergy definition supplies.

R3K5→K6precedesTest it

Dividing zero-synergy net income by pro forma shares consumes the combined net income result from step four.

R4K5↔K6confused withTest it

Learners conflate building the zero-synergy net income numerator with dividing it by pro forma shares.

R5K7→K6precedesTest it

Multiplying the per-share shortfall by share count consumes the zero-synergy pro forma EPS and share count result first.

R6K8→K7precedesTest it

Grossing up to pre-tax requires the after-tax synergy shortfall figure that step six produces.

1. K1The $80 is the offer price payable at closing.
2. K2The gap between the offer price and the trading price is the merger arbitrage spread.
3. K3Between announcement and close, the target's shares typically trade below the offer price.
4. K4Time value: the $80 is only received at a future close, and an arbitrageur buying below $80 earns a return over the waiting period — the market discounts the offer back at the return demanded for that time.
5. K5Execution risk: the deal may never close, because regulators can block it on antitrust grounds, shareholders can vote it down, financing can fall through, or a material adverse change can let the buyer walk.
6. K6The more execution risk the market perceives, the wider the spread and the further the stock trades below the offer.
7. K7Business risk: the target is still a living company between signing and closing, and market volatility or something impairing its standalone value can prevent the deal from closing.
8. K8If part of the consideration is acquirer stock, the value the target's holders receive moves with the buyer's share price.
9. K9Example: a sinkhole that destroyed a company's headquarters led to a deal's cancellation.

R1K4→K3causesTest it

Discounting the future $80 for time value alone makes the target trade below offer price.

R2K5→K6causesTest it

Perceived execution risk directly widens the spread; without it the stock would sit nearer the offer.

R3K6→K3requiresTest it

Attributing the below-offer gap to execution risk presupposes the target already trades below the offer.

R4K7→K6applies withinTest it

Business risk only widens the spread because it is one channel feeding perceived execution risk.

1. K1A sources and uses schedule is a two-sided summary: the left shows where the deal's funding comes from, the right shows where every dollar goes.
2. K2New debt is broken out by tranche and seniority, each tranche listed as its own source line.
3. K3The buyer's or sponsor's equity contribution appears as its own source line.
4. K4Cash already sitting on the target's balance sheet can be put to work as a source.
5. K5Rollover equity, where management or existing owners keep a stake rather than cashing out fully, is sometimes a source.
6. K6The biggest use is usually the equity purchase price, the cost of buying the target's shares.
7. K7A use is paying off the target's existing debt, along with the transaction and financing fees paid to bankers and lawyers.
8. K8A use is any cash left on the balance sheet to fund the combined business, plus working capital adjustments if the actual closing balance sheet differs from what was assumed.
9. K9The two sides must tie: every dollar of sources is spent on a use, so the totals are always equal.

R1K1→K6applies withinTest it

The claim in [5] that equity purchase price is the biggest use only makes sense inside [0]'s sources-and-uses framing.

R2K1→K7applies withinTest it

Debt payoff and transaction fees in [6] are only categorized as uses because [0] defines the right side as uses.

R3K6↔K7confused withTest it

Learners conflate the equity purchase price use with the target debt payoff and fee use, stating one when they mean the other.

R4K9→K1requiresTest it

The two-sided totals-equal definition in [0] cannot be stated without already having [8]'s tying rule in hand.

1. K1Value arbitrage is buying the target for less than its intrinsic value or net asset value.
2. K2If the target's assets and going-concern value are worth $100 and the acquirer negotiates a price of $80, that $20 gap accrues to the acquirer's shareholders.
3. K3The gap arises when the market has mispriced the target or a distressed seller must transact.
4. K4Second way: synergies — the combined entity is worth more than the sum of the two companies separately
5. K5Synergies come from cost sources such as eliminating duplicated overhead and consolidating procurement, and from revenue sources such as cross-selling to each other's customers or combining distribution
6. K6Synergies are worth the present value of incremental cash flows net of one-time costs to achieve them
7. K7The real test of value creation is whether the purchase price is below the target's standalone value plus synergies, not whether EPS goes up.
8. K8Accretion is an EPS accounting outcome, while value creation means acquirers' shareholders are genuinely wealthier — the two can diverge.

R1K1→K2requiresTest it

The $20-gap example only delivers shareholder value if the $80 price is genuinely below intrinsic value.

R2K1↔K4confused withTest it

Both are named ways acquisition creates value, so learners swap the arbitrage gap with the synergy surplus.

R3K3→K1causesTest it

The mispricing/distress condition is what makes the below-intrinsic-value purchase possible rather than random luck.

R4K4→K7requiresTest it

The price-below-standalone-plus-synergies test only makes sense once synergies are defined as the second value source.

R5K6→K4applies withinTest it

PV of incremental cash flows net of integration costs governs how much synergy value the second method actually contributes.

R6K7→K8precedesTest it

You cannot distinguish value creation from accretion until you have the purchase-price-versus-value test in hand.

1. K1A company acquired with 50% debt and 50% equity, generating cash flow over five years and then sold, is a leveraged buyout (LBO).
2. K2The buyer in this scenario is a financial buyer — a private equity sponsor — rather than a strategic acquirer.
3. K3The scenario carries three classic fingerprints of an LBO: funding, horizon, and exit.
4. K4The 50% debt/equity funding is a heavily leveraged purchase characteristic of sponsors.
5. K5Sponsors use debt so they can control a large asset with only a small equity check.
6. K6The five-year horizon matches the typical PE fund life, because PE funds are closed-end vehicles that must return capital to their limited partners.
7. K7The planned exit at around five years distinguishes the sponsor from a strategic acquirer: the sponsor crystallizes its return by selling the company or taking it public, whereas strategic acquirers buy to hold indefinitely.
8. K8High leverage, a defined holding period, and a planned exit point squarely to an LBO by a financial buyer.

R1K1→K2requiresTest it

Identifying the deal as an LBO does not by itself force the buyer-type claim, which is the specific link learners drop.

R2K4→K3applies withinTest it

The leverage fingerprint only counts as a classic LBO signature once the funding/horizon/exit frame is in place.

R3K5→K4causesTest it

If sponsors could control large assets with tiny equity checks without debt, the 50/50 leverage would stop being the sponsor fingerprint.

R4K6→K7causesTest it

The fund-life constraint drives the need to exit on schedule, which is what separates the sponsor from a buy-and-hold strategic.

R5K7→K2requiresTest it

You cannot call the buyer a financial rather than strategic buyer until the planned-exit distinction has been established.

1. K1WACC is the rate compensating capital providers for risk, so the discount rate must match the risk of the specific cash flows being discounted
2. K2The target's standalone cash flows should be discounted at the target's WACC, regardless of who the acquirer is
3. K3Applying the acquirer's lower WACC to risky target cash flows overstates their present value, because the acquirer's balance sheet does not make the target's business less risky
4. K4Synergies are cash flows that exist only because the acquirer owns the target, so they are the acquirer's cash flows
5. K5If the acquirer's lower cost of capital applies after the deal closes, the synergies should be discounted at the acquirer's WACC
6. K6The discipline is one rate per cash-flow stream: target WACC for target flows, acquirer WACC for synergies

R1K1→K2requiresTest it

The match-rate-to-cash-flows principle forces using the target's WACC for target flows, regardless of acquirer.

R2K2→K3requiresTest it

You cannot claim overvaluation without already having established that target flows take the target's higher WACC.

R3K4→K5causesTest it

Calling synergies the acquirer's cash flows is what licenses discounting them at the acquirer's WACC.

R4K5↔K6confused withTest it

Both pick a rate for synergies, so learners state one while meaning the other.

R5K6→K5precedesTest it

The one-rate-per-stream rule is the principle that yields the acquirer WACC for synergies.

1. K1The premium is the amount paid above the target's unaffected share price, and all-stock deals typically fetch the higher premium
2. K2In an all-stock deal the seller becomes a shareholder of the combined company and bears the downside if the merger underperforms
3. K3Because the target receives the buyer's shares rather than cash, its ultimate payout depends on the post-close trading performance of those shares, so the target demands a larger premium as compensation for the riskier currency
4. K4Offering stock can signal the buyer believes its own shares are overvalued, so the target demands more stock — a bigger premium — as compensation
5. K5Cash has certainty of value
6. K6Cash puts all the risk on the buyer
7. K7The certainty of cash for both sides is why all-cash deals command lower premiums than all-stock deals

R1K2→K3requiresTest it

The risk-shifting explanation only holds because the seller is paid in shares and therefore bears post-close downside.

R2K3→K1causesTest it

The riskier stock currency compels the buyer to offer a larger premium, which is why all-stock deals fetch higher premiums.

R3K3↔K4confused withTest it

Both explain higher stock premiums, but one is risk compensation and the other is signaling.

R4K4→K3causesTest it

Overvaluation signaling makes shares less acceptable as currency, reinforcing the need for a larger risk premium.

R5K5→K7causesTest it

Cash's certainty of value is the reason all-cash deals command lower premiums than stock deals.

R6K5→K6causesTest it

Because cash has certain value, the buyer absorbs the merger's downside risk entirely.

R7K6→K7causesTest it

Buyer bearing all risk under cash reduces the compensation sellers require, producing lower cash premiums.

1. K1The consideration choice determines the value certainty, upside exposure, and tax treatment the target's shareholders face after closing
2. K2For stock, the deal is signed at a fixed exchange ratio, so swings in the acquirer's share price change the value the seller actually receives
3. K3If the acquirer's stock trades in a frothy or overvalued market, the paper the seller accepts may be worth much less once a correction comes
4. K4The target should assess the acquirer's expected performance, since the stock's future worth depends on how the buyer performs after the deal closes
5. K5Stock consideration can often be structured as a tax-deferred reorganization, letting the seller postpone capital gains until the shares are sold
6. K6Stock gives the target shareholders upside participation — they share in the synergies and future growth of the combined company
7. K7For cash, the value is certain and not dependent on the buyer's future performance or on market movements before closing
8. K8Cash lets the target capture the full upside directly, with the value locked at close and nothing left to share with the buyer
9. K9Cash is directly taxed: the seller realizes the gain immediately, so after-tax proceeds are lower than the headline price

R1K2→K3applies withinTest it

Froth risk only matters because the fixed exchange ratio in KLP1 makes the seller's received value float with the acquirer's price.

R2K4→K6requiresTest it

Claiming upside participation in the combined company is empty unless you first know the stock's worth depends on the buyer's post-deal performance.

R3K5→K1applies withinTest it

Tax deferral only enters the consideration trade-off because KLP0 frames the choice as setting value certainty, upside, and tax treatment together.

R4K8↔K9confused withTest it

Both say cash lets the target capture value directly, so a learner may state the tax hit when they mean the upside capture.

1. K1Stock financing conserves the buyer's cash and avoids adding leverage to the balance sheet.
2. K2Stock shares risk with the seller because target shareholders receive shares in the combined company and keep exposure to its post-deal performance.
3. K3The cost of stock financing is dilution — existing shareholders' ownership and claim on earnings shrink.
4. K4Stock is the best currency when management believes its stock is overvalued, making that paper comparatively cheap financing.
5. K5Stock is a bad choice when markets are poor or the stock is undervalued.
6. K6Cash is best when the buyer has excess cash above operating needs earning low returns, and bad when spending it leaves no buffer for normal operations or a downturn.
7. K7Debt is best when the company has debt capacity and capital markets can lend.
8. K8Debt capacity isn't only EBITDA-based — asset-backed facilities and convertible debt also qualify.
9. K9Debt is a bad choice when the company is already overlevered or debt market conditions are poor.

R1K1→K4applies withinTest it

Overvaluation makes stock cheap financing only because stock's cost is dilution to existing owners, which stock conservation alone does not price.

R2K3→K5causesTest it

Once issuing stock is recognized as diluting owners, undervalued or poor markets make that dilution a realized loss, flipping stock to a bad choice.

R3K4→K5precedesTest it

You cannot state when stock is a bad choice without first having the overvaluation-as-cheap-currency criterion whose mirror image defines the bad case.

R4K7→K8requiresTest it

Practical debt capacity must include asset-backed and convertible facilities, or the claim that debt works whenever capacity exists collapses.

1. K1A synergy is value created by combining two companies that neither could capture alone, and it comes in cost and revenue forms
2. K2Cost synergies are the elimination of overlapping expense that exists because both companies already incur it — the target's duplicate headcount, facilities, or vendor spend is removed, so the saving is a subtraction from the combined cost base rather than a new source of value
3. K3A cost synergy program can be sized and underwritten as a specific dollar figure before closing, because each line item maps to an identified duplicate that appears in the combined accounts
4. K4Revenue synergies require a third party to change behavior after the deal — a customer must buy a cross-sold product or a sales team must push a new offering — so the lift cannot be counted on merely because the two businesses are combined
5. K5Cost synergies are easier to achieve because they sit under management's direct control and can be executed against a specific line-item plan
6. K6Revenue synergies are harder because they depend on unpredictable customer behavior — customers may not buy the bundled offering and sales teams may not push it
7. K7Cost synergies are also faster to realize than revenue lifts, which is why acquirers typically underwrite deals primarily on the cost side

R1K2→K5causesTest it

If cost synergies were not subtractions of pre-existing duplicate spend, they would not be within management's direct control and easier to achieve.

R2K2↔K4confused withTest it

Learners often state cost synergies as a subtraction from combined cost base while describing revenue synergies as any post-deal value creation.

R3K4→K6causesTest it

If revenue synergies did not require third-party behavior change, customer unpredictability would not make them harder to achieve.

R4K4→K3requiresTest it

Sizing cost synergies pre-closing as a dollar figure only works because cost savings, unlike revenue synergies, need no third-party behavior change.

1. K1EPS is net income divided by shares outstanding, so accretion/dilution measures what the deal does to each shareholder's slice of combined earnings
2. K2A deal is accretive if post-acquisition EPS rises and dilutive if it falls
3. K3Accretion is a quick, visible proxy for the immediate impact on shareholder value — it suggests the buyer paid a sensible price relative to the earnings acquired
4. K4Accretive deals generally boost investor sentiment and the stock price, while dilutive deals do the opposite
5. K5Because EPS is one of the most-watched metrics for shareholders, announced accretion or dilution acts as a key market signal of the deal's value and future performance
6. K6Strategic buyers' management teams are incentivized to grow EPS because their compensation packages are often tied to EPS targets

R1K2→K3requiresTest it

You cannot claim accretion suggests the buyer paid sensibly without first having the EPS-rise condition that constitutes accretion.

R2K4→K5causesTest it

If accretion did not move sentiment and price, announced EPS changes could not function as the market signal described in KLP 4.

R3K6→K4applies withinTest it

EPS-driven compensation only explains why management pushes accretive deals if accretion also moves sentiment and price.

1. K1Short-term accretion/dilution is the immediate EPS impact at close, largely a mechanical outcome of the deal math
2. K2A deal tends to be accretive on day one if the target's earnings yield exceeds the after-tax cost of the cash or debt financing it
3. K3Buying a lower-P/E target with higher-P/E stock is mechanically accretive, which is why relative P/E drives short-term impact
4. K4Long-term value depends on synergies — cost cuts and revenue lifts that phase in over years.
5. K5Because synergies ramp over time, a deal that is dilutive in year one can become increasingly accretive in later years, so the year-one EPS number is not the correct verdict on the deal.
6. K6Yes, companies do buy dilutive deals — the correct test is whether long-term synergies and strategic value outweigh the immediate EPS dilution
7. K7Short-term dilution is acceptable when the synergy pool is large and credible.
8. K8Dilution with no credible synergy path behind it is what a disciplined acquirer should refuse — the absence of a synergy case, not the dilution itself, is the disqualifier.

R1K2→K3precedesTest it

The relative-P/E explanation of accretion is derived from the same earnings-yield-versus-cost comparison that drives day-one accretion.

R2K3↔K5confused withTest it

Both explain why the year-one EPS number is not a verdict, but one is mechanical P/E arbitrage and the other is synergy timing.

R3K5→K6causesTest it

If synergies did not phase in over years, year-one dilution would be a permanent verdict and buying a dilutive deal could never be justified.

R4K5→K7requiresTest it

Tolerating dilution only makes sense because the synergy ramp lets a year-one dilutive deal become accretive later.

R5K7→K6precedesTest it

You cannot state the general rule that companies buy dilutive deals without first having the condition under which such dilution is acceptable.

R6K8→K7requiresTest it

Refusing dilution without a credible synergy path only has teeth if the large-synergy case genuinely justifies the same dilution.

1. K1Two companies with $100 each should combine to roughly $200, so $220 pre-synergies is a premise error — the two revenue figures are not measured on the same basis
2. K2The first question is what 'revenue' means here — is each figure LTM or the previous fiscal year? Only after confirming that should you hunt for explanations
3. K3Because 'revenue' is ambiguous, a candidate who shows the $20 gap must identify which specific timing convention — LTM versus prior fiscal year — accounts for the mismatch, not merely note that revenue is ambiguous
4. K4If one figure is LTM and the other is the prior fiscal year, or the two companies have different fiscal calendars with one rolled forward onto the buyer's fiscal year, the combined figure picks up extra months of one company's revenue
5. K5Timing mismatch alone can explain the gap — question the premise before assuming the numbers are wrong
6. K6The second suspect is currency: Company B may be overseas and reported in local currency
7. K7The combined figure depends on when the exchange rate was struck — if the translation uses today's rate and the local currency strengthened since the reporting date, the target's revenue in dollars is higher than reported, producing a combined number above $200
8. K8The $20 gap pre-synergies is almost certainly a measurement-basis error; the places to check are timing first — LTM vs fiscal year and calendar alignment — then the FX rate used for translation

R1K1↔K2confused withTest it

Asking what 'revenue' means can be mistaken for asserting the premise is simply wrong, when the first is a diagnostic step and the second is a conclusion.

R2K3→K2requiresTest it

Naming the specific timing convention (LTM vs fiscal year) that explains the gap presupposes having first pinned down what each revenue figure means.

R3K4→K8causesTest it

If LTM-vs-fiscal-year or calendar misalignment rolls extra months into the combined figure, that is what makes timing the first place to check the gap.

R4K6→K3applies withinTest it

Substituting a domestic Company B makes timing mismatch the sole suspect, so the LTM-vs-fiscal-year requirement only bites inside the counterfactual where B is overseas.

R5K7→K6requiresTest it

The FX translation explanation only becomes applicable after establishing that Company B reports in a foreign local currency.

1. K1A spinoff distributes shares of the division to existing shareholders as a separate listed company, so no third-party buyer is needed
2. K2A spinoff can be structured tax-free because it is a pro-rata distribution to shareholders you already have
3. K3A spinoff unlocks shareholder value by exposing an undervalued division and lets the parent retain exposure to the child company's upside
4. K4Spinoff downsides: shareholders can't readily convert the stake to cash, no control premium is paid since there's no buyer, execution is slow, and it depends on capital markets being receptive
5. K5A divestiture is an outright sale to a third party — it brings immediate cash, faster execution, a cleaner break, and a potential premium when sold to a synergy-paying competitor
6. K6Divestiture downsides: the sale is generally taxable, third-party execution risk exists, and you typically hand the business to a direct competitor
7. K7The choice comes down to a trade-off between speed of cash from a third-party sale and retained exposure to the business through a spinoff

R1K1→K7precedesTest it

You cannot frame the speed-versus-retained-exposure trade-off without first knowing a spinoff needs no third-party buyer.

R2K1↔K5confused withTest it

Both split off a division, so learners conflate the no-buyer distribution with the third-party sale.

R3K2→K1requiresTest it

Tax-free treatment hinges on the pro-rata distribution being to existing shareholders, which is what defines the spinoff itself.

R4K2→K4causesTest it

The no-buyer distribution that makes the spinoff tax-free is exactly what removes any control premium and cash conversion.

R5K3→K1requiresTest it

Retaining upside and unlocking value only makes sense if the division becomes a separately listed entity held by existing shareholders.

R6K4↔K6confused withTest it

Both are downside lists, so learners attribute a spinoff drawback like no cash to a divestiture.

R7K5→K6causesTest it

Selling outright to a third party for a premium is precisely what makes the deal taxable and hands the business to a competitor.

R8K5→K7precedesTest it

The speed-of-cash side of the trade-off consumes the divestiture idea that an outright sale delivers immediate cash.

1. K1Debt/EBITDA is debt divided by EBITDA, so an overlevered buyer only has two levers: reduce the numerator or grow the denominator
2. K2What matters is the relative percentage change — the ratio falls if EBITDA grows proportionally more than debt, or debt falls proportionally more than EBITDA
3. K3Buying a lower-levered target and paying with stock issuance or cash rather than new debt raises combined debt far less than combined EBITDA, so the blended ratio falls
4. K4Structuring part of the purchase price as earn-outs lowers the cash that has to be borrowed at close, cutting debt raised upfront
5. K5Divesting non-core assets after close and applying the proceeds to debt paydown directly reduces the numerator
6. K6A target with high current EBITDA and credible expected synergies lifts the denominator without adding debt, mechanically lowering the combined ratio
7. K7The profile sought: a lower-levered, high-EBITDA target with strong synergies, financed with stock or cash, with earn-outs and post-close divestitures trimming the debt actually raised

R1K1→K2precedesTest it

The percentage-change comparison in KLP 1 only makes sense once the numerator/denominator framing of KLP 0 is in hand.

R2K2→K6requiresTest it

The synergy EBITDA lift in KLP 5 only lowers the ratio under KLP 1's proportional-change condition, not by absolute growth.

R3K3→K7applies withinTest it

The stock/cash financing condition in KLP 2 is what makes KLP 6's target profile actually delevering rather than neutrally accretive.

R4K3↔K6confused withTest it

High-EBITDA targets and low-levered targets both lower a blended ratio but through opposite arithmetic mechanisms.

R5K4→K7requiresTest it

Stating the earn-out financing feature of the sought profile in KLP 6 consumes KLP 3's result that earn-outs defer borrowed cash.

1. K1Both a merger and an acquisition produce one combined company; the operational distinction is who captures the control premium, while legally the line between the two can blur.
2. K2In a true merger, the premium is shared roughly equally because neither side is clearly the controller — it's a partnership of near-peers.
3. K3Because the value exchanged in a true merger is equity itself, these deals are almost always stock-for-stock at a fixed exchange ratio, and each side's shareholders end up owning the combined company in proportion to what they contributed.
4. K4In an acquisition, the buyer is clearly in control, and the premium is paid as the price of taking over the board and the decisions.
5. K5In an acquisition, the buyer pays a full control premium to the target shareholders, typically 20-40% over the standalone share price.
6. K6In every case the premium is explicitly negotiated and paid to the target side only.
7. K7The difference that decides which you have: a merger splits the premium between both shareholder groups, an acquisition hands it entirely to the target's shareholders.

R1K2↔K4confused withTest it

Both KLPs describe who holds control, so learners conflate the acquirer's control with the merger's absence of one.

R2K3→K2requiresTest it

Equal premium sharing is grounded in the symmetric stock ownership each side receives, so the true-merger premium split depends on the fixed-exchange-ratio mechanism.

R3K4→K5causesTest it

Buyer control is what forces payment of the full control premium to the target, so removing control removes the premium logic.

R4K6→K7precedesTest it

You must first know the premium is negotiated and paid to the target side before deriving that a merger splits it and an acquisition doesn't.

1. K1In stock-for-stock M&A, stock consideration comes in three forms: fixed exchange ratio, floating exchange ratio, and collar
2. K2A fixed exchange ratio locks the number of buyer shares per target share at signing, so the value delivered floats with the buyer's stock price and the buyer absorbs the price risk
3. K3A floating exchange ratio (fixed value) sets the dollar value per target share and adjusts the share count at close, shifting risk to share dilution
4. K4A collar floats the exchange rate but caps it, limiting the swing of either pure structure
5. K5Walk-away rights are contractual outs that let a party exit the deal, typically arising on a material adverse change or unmet conditions
6. K6Cash election or mixed consideration lets target shareholders choose between pure cash and a stock-plus-cash package
7. K7CVRs are contingent value rights that pay target holders extra only if defined future events occur — effectively an earn-out in public deal form

R1K1→K2precedesTest it

You cannot define the fixed-ratio variant before establishing that stock consideration has exactly three ratio structures.

R2K2→K3causesTest it

If fixed ratio locks shares and floats buyer value, the alternative floating ratio must instead fix value and float share count.

R3K2↔K6confused withTest it

Learners conflate a fixed exchange ratio's locked share count with a cash election's locked per-share consideration choice.

R4K3→K4causesTest it

Because floating fully shifts risk to dilution, a collar exists to cap that swing and limit either pure structure's range.

R5K5→K7requiresTest it

CVRs pay only on defined future events, so their enforceability presupposes walk-away rights tied to unmet conditions and MAC.

1. K1A fixed exchange ratio sets the number of acquirer shares per target share at signing, and that ratio does not adjust as stock prices move
2. K2Because the ratio is fixed, the acquirer has committed to a fixed number of its own shares, so the total value it hands over rises and falls with its share price at close
3. K3When the acquirer's stock rises, that increase in value handed over flows to the target's shareholders, who receive shares now worth more than at signing
4. K4The target side therefore captures the benefit of the acquirer's higher share price, while the acquirer receives the same target and no additional consideration
5. K5The acquirer is effectively paying a higher price for the same target and getting nothing extra in return — bad for the acquirer

R1K1→K2precedesTest it

Deriving that consideration value moves with the acquirer's price requires the ratio be fixed in shares.

R2K2→K3causesTest it

A fixed share count only benefits the target because those shares become worth more at close.

R3K2→K5requiresTest it

Concluding it is bad for the acquirer needs the prior result that the value handed over rose with the stock.

R4K3→K4precedesTest it

Stating the target captures the gain requires already knowing the target's shares are worth more at close.

R5K4→K5causesTest it

Given the target gains while the acquirer gets no extra consideration, the acquirer is worse off.

1. K1The premium paid is a prepayment of expected synergies — the deal creates value only if the present value of synergies exceeds that premium
2. K2If the premium exceeds the synergies, the combined entity is worth less than what was paid for it — that is value destruction
3. K3Accretion is an accounting test — whether combined EPS rises — and is separate from the economic question of whether value was created
4. K4The premium can exceed the present value of realized synergies after the deal closes, destroying value even though the deal was underwritten as accretive
5. K5Buying a lower-P/E target with stock mechanically raises EPS even when no real value is created, so accretion alone can signal value creation when there is none
6. K6If the target's value declines after the deal, its P/E stays below the buyer's so EPS still looks accretive, yet combined value is less than the two standalone companies
7. K7The deal itself can cause deterioration — consolidated revenue can fall below the two companies' separate revenues through customer loss or channel conflict
8. K8Hidden liabilities discovered post-close erode the value the premium was underwritten by, another way an accretive deal destroys value

R1K2→K1requiresTest it

Value destruction can only be defined as premium exceeding synergies if value creation is first framed as premium-versus-PV-of-synergies.

R2K3→K4precedesTest it

Calling a deal accretive yet value-destroying requires first separating the EPS accounting test from the economic value test.

R3K5→K3causesTest it

Learners conflate the EPS rise from a lower-P/E stock deal with economic value creation because accretion is treated as the value test.

R4K6→K5applies withinTest it

The persistent low-P/E target mechanism is one concrete case of stock-funded lower-P/E acquisitions mechanically lifting EPS without real value creation.

R5K7→K1causesTest it

Revenue deterioration directly reduces realized synergies, so it causes the premium to exceed the synergy PV that justified the deal.

1. K1Position the company as a diversifier acquisition rather than a bolt-on: because it sells through big-box retail, Amazon and DTC, no single channel failure would collapse revenue, which de-risks the revenue base for any acquirer — the headline of the sale pitch.
2. K2The DTC business is strategically valuable in its own right because it owns the customer relationship and supplies first-party data, which a strategic buyer can apply across its portfolio for targeting, product development and retention.
3. K3The company manufactures in-house in the US, which means shorter lead times, tighter quality control and less exposure to overseas logistics risk.
4. K4That US manufacturing base is a real supply chain advantage in an environment where resilience matters.
5. K5It is a premium luxury brand, which means pricing power and the ability to hold price and margin in the luxury personal care segment.
6. K6Strategic buyers are generally horizontal integrators — players at the same level of the value chain who want to add a complementary brand rather than buy a supplier or customer.
7. K7There is also a semi-vertical play: big-box retailers increasingly carry their own soap lines and might want to expand into private-label wellness.
8. K8Buyer type one: large CPG companies such as P&G, L'Oréal and Unilever looking to expand their premium and luxury portfolios.
9. K9Buyer type two: mid-market beauty platforms backed by private equity that are rolling up brands and could bolt this onto an existing portfolio; buyer type three: a retailer seeking vertical integration into private-label luxury goods, which the domestic manufacturing capability would directly support.

R1K2→K1requiresTest it

The diversifier/derisking pitch cannot hold if DTC does not own the customer relationship.

R2K3→K4causesTest it

US in-house manufacturing (lead times, QC, logistics) is what makes the supply-chain resilience claim true.

R3K3→K9requiresTest it

Retailer vertical integration into private-label luxury can only be supported if the domestic manufacturing capability exists.

R4K6→K8applies withinTest it

The horizontal-integrator definition of strategic buyers is the frame that makes CPG premium-portfolio buyers count as strategic.

R5K6→K7applies withinTest it

The semi-vertical big-box private-label play only makes sense as the exception to horizontal-integrator strategic buyers.

R6K6↔K7confused withTest it

Big-box private-label entry is a vertical play, not a horizontal same-level buyer, so the two are easily conflated.

1. K1The ownership split is driven solely by how much new equity is issued relative to total equity after the raise, not by how the purchase price is funded.
2. K2Raising $5 million of equity on top of $10 million of existing equity value makes post-raise equity $15 million; the PE firm holds one-third and the original owners hold two-thirds.
3. K3The PE firm writes the same $5 million equity check either way.
4. K4Debt only changes the leverage on the balance sheet — more interest expense and financial risk — but it does not change equity value.
5. K5Equity value is what ownership is measured against.
6. K6Because the equity investment is identical in both cases, the ownership split is the same whether the acquisition is funded 100% with cash or 50/50 cash and debt.

R1K2→K1causesTest it

The numbers in [1] make the general principle in [0] true; without them [0] has no force.

R2K4→K6causesTest it

If debt changed equity value, the funding mix would change the split, breaking [5].

R3K5→K2requiresTest it

Claiming one-third/two-thirds requires already treating equity value, not debt or cash, as the base.

R4K6→K2requiresTest it

The same-split conclusion presumes the one-third/two-thirds base case, which is often substituted by a wrong cash-vs-debt base.

1. K1If the target's owners refuse to accept the acquirer's stock, the acquirer can raise cash by issuing new shares to public investors in a follow-on equity offering, instead of handing stock directly to the target's owners.
2. K2Stock is the only consideration the acquirer can offer directly when the target's owners will not take stock.
3. K3The cash raised in the follow-on offering is paid to the target's owners, so the sellers receive cash rather than stock.
4. K4Risk: capital markets may be unfavorable at the time of the raise, forcing poor terms and fewer dollars per share issued, which makes the acquisition more expensive than planned.
5. K5Risk: the new issuance dilutes existing shareholders, who then own a smaller slice of the company.
6. K6Risk: a large new issuance increases the supply of shares in the market, which pushes the stock price down.
7. K7Risk: an offering on weak terms can signal distress, which pushes the stock price down.
8. K8Risk: both increased share supply and the distress signal push the stock price down, and that decline raises the effective cost of the financing.
9. K9Risk: if the market turns against the offering entirely, the acquirer may not be able to raise the cash at all, which puts the whole transaction's financing at risk.

R1K1→K2causesTest it

The follow-on offering mechanism exists precisely because direct stock consideration is categorically unavailable to target owners.

R2K1→K3requiresTest it

The sellers receiving cash depends on the follow-on raise completing and being paid to them.

R3K4→K9causesTest it

Unfavorable terms and fewer dollars per share are the mechanism that can escalate to a failed raise.

R4K4↔K8confused withTest it

Bad offering terms and the combined supply-plus-signal price decline both raise effective financing cost.

R5K6→K8applies withinTest it

The combined price-decline mechanism only holds because increased share supply depresses the price first.

1. K1A working capital peg is a target level of net working capital the seller must deliver at closing so the business can operate normally from day one.
2. K2Net working capital means current assets minus current liabilities, typically excluding cash and debt.
3. K3Without a peg, the seller can strip working capital before handover — aggressively collecting receivables or stretching payables — leaving the buyer a business short of operating cash.
4. K4The peg is usually set off a historical average of normalized NWC, with a closing true-up adjusting the purchase price dollar-for-dollar for the difference.
5. K5The seller wants a lower peg, because delivering less working capital lets them extract more cash from the business before the buyer takes over.
6. K6The buyer wants a higher peg, because more current assets come with the business at no cost beyond the agreed purchase price.
7. K7A higher peg benefits the buyer because the seller must leave more cash and current assets in the business at closing than the buyer effectively pays for through the price adjustment.

R1K3→K1requiresTest it

The peg's purpose presupposes the stripping risk; without that risk, the defined target level has no function.

R2K4→K1precedesTest it

You cannot state the peg as a target without the historical-average and true-up mechanism that sets it.

R3K4→K7causesTest it

The true-up mechanism's dollar-for-dollar adjustment is what makes leaving more assets effectively free to the buyer.

R4K5↔K6confused withTest it

Learners may conflate the seller's preference with the buyer's, stating both want the same peg direction.

1. K1EBITDA is earnings before interest, taxes, depreciation, and amortization — operating profitability before financing and tax effects.
2. K2Net income sits below all of those lines, so it is an after-tax, after-financing figure.
3. K3Adding net income to EBITDA double counts interest, taxes, and D&A, because net income already includes the EBITDA components, and produces a meaningless blended number.
4. K4Instead, merge each underlying line item individually — combine revenue with revenue and each operating expense with its counterpart.
5. K5Then rebuild the combined EBITDA from those merged line items from the ground up, rather than adding one company's bottom line to the other's EBITDA.

R1K1→K3applies withinTest it

Double counting is only diagnosable under the EBITDA definition excluding interest, taxes, depreciation, and amortization.

R2K2→K3requiresTest it

The double-counting claim only follows because net income already contains interest, taxes, and D&A beneath the EBITDA line.

R3K3→K4causesTest it

Recognizing that bottom-line addition double counts forces the decision to merge individual line items instead.

R4K4→K5requiresTest it

Rebuilding combined EBITDA from merged line items presupposes the merged line items already exist from step 3.

R5K4↔K5confused withTest it

Learners conflate merging counterpart line items with rebuilding EBITDA, treating the merge itself as the rebuilt figure.

1. K1An acquisition is accretive when the value the target brings exceeds what the buyer pays for it — the deal adds to the buyer's worth.
2. K2Accretion is measured on reported results, not projections: pro forma EPS — standalone buyer EPS plus the target's contributed earnings, adjusted for new shares and after-tax financing costs — must come out higher than the buyer's standalone EPS.
3. K3EPS accretion occurs when the target's earnings contribution exceeds the after-tax cost of financing — interest on new debt plus earnings spread over newly issued shares.
4. K4The second test compares yield — the return on the investment, effectively target earnings or EBITDA over purchase price — to the WACC.
5. K5WACC represents the blended cost of the debt and equity used to finance the acquisition.
6. K6Value creation requires the acquired yield (target earnings or EBITDA over purchase price) to exceed the buyer's WACC; the deal is dilutive to value, not merely to EPS, when that yield falls short of the cost of capital.
7. K7The two tests can diverge: a cheap debt-funded deal can be EPS-accretive yet still destroy value if the yield doesn't clear the cost of capital.

R1K2→K3requiresTest it

The financing-spread condition is the mechanism you must have already derived to compute pro forma EPS.

R2K3↔K4confused withTest it

Learners conflate the EPS financing-spread test with the yield-versus-WACC value test.

R3K5→K6requiresTest it

The yield-vs-WACC test cannot be stated without already having WACC's definition in hand.

R4K5→K6applies withinTest it

Counterfactual where WACC is only an equity cost breaks the yield-clears-cost-of-capital claim.

R5K6→K7precedesTest it

Showing the two tests diverge requires already having the value-destruction condition from yield shortfall.

1. K1(definition) This is an inbound offer, and the advisor's job is to ensure the client sells at full value or not at all
2. K2(mechanism) Before reacting to $2B, establish fair value with DCF, trading comps, and precedent transactions, since the headline price is meaningless without a benchmark
3. K3(mechanism) Research the buyer's past acquisitions and motivation to judge whether they're a credible strategic or financial payer and whether the offer is firm or an opener
4. K4(causal) An unsolicited offer is usually an opening position, so the advisor creates competitive tension around it
5. K5(mechanism) Create tension by preparing a CIM, marketing to other logical buyers, and soliciting LOIs so the original buyer knows they face competition
6. K6(mechanism) Drive process on deal terms — management presentations, term sheets, and final bids — comparing structure, financing certainty, and regulatory risk, not just headline price
7. K7(condition) Evaluate alternatives — staying independent, IPO, recapitalization, another buyer — because $2B must beat the best standalone plan on a risk-adjusted basis
8. K8(contrast) Present a formal recommendation with valuation and process results, but the board makes the decision and the banker only advises

R1K2→K4causesTest it

Knowing fair value is what makes an unsolicited bid look like an opener rather than a gift.

R2K2→K7requiresTest it

You cannot judge whether $2B beats staying independent without the risk-adjusted standalone valuation already in hand.

R3K2↔K3confused withTest it

Both are pre-reaction diligence, so learners swap valuing the target with researching the buyer's credibility.

R4K4→K5causesTest it

Framing the bid as an opening position is what justifies building a competitive process instead of replying directly.

R5K4→K6precedesTest it

Running a full bid process only makes sense once the offer is treated as an opener rather than a final price.

R6K6→K8precedesTest it

The board cannot weigh a formal recommendation until process results comparing structure and financing certainty exist.

1. K1Beyond the income statement and balance sheet, start with the cash flow statement, because for an acquisition you care about actual cash generation, not accrual earnings
2. K2Want historical financials going back several years to see whether growth and margins are stable trends
3. K3Want the deal terms: the asking price and how the deal is financed — cash, stock, or debt
4. K4If there is existing debt, ask for the full debt schedule, specifically covenants, maturities, and change-of-control provisions
5. K5Ask for a customer and revenue breakdown to spot concentration risk
6. K6Want comparable transactions to benchmark the price
7. K7Want off-balance-sheet obligations — operating leases, pending litigation, and pension deficits — which are real liabilities the balance sheet does not show
8. K8Want a short bio on the management team
9. K9Request management's projections along with the underlying model and its assumptions so the forecast can be pressure-tested

R1K1→K2requiresTest it

Reading cash generation from the cash flow statement presupposes multi-year historicals so the cash trend isn't a single-period artifact.

R2K3→K6requiresTest it

Comparable transactions only benchmark a price if the deal terms (price and financing structure) are already known.

R3K4↔K7confused withTest it

Learners conflate on-balance-sheet debt covenants with off-balance-sheet obligations, treating one as covering the other.

R4K9→K2requiresTest it

Projections cannot be pressure-tested without historical financials establishing the trend baseline the forecast extends.

1. K1A sell-side pitchbook sells the deal story to a seller — it is a marketing document presented to win a mandate to sell the company.
2. K2I'd open with an executive summary, then the strategic rationale for why a sale creates value now.
3. K3Next comes a target overview covering product, history, customers, and strategy, followed by industry analysis in market context.
4. K4The analytical core is the valuation analysis: it uses trading comparables, precedent transactions, and a DCF to reach an implied sale value.
5. K5Valuation analysis is supported by historical and projected financials.
6. K6I'd add an accretion/dilution analysis showing the EPS impact for likely buyers.
7. K7Then the proposed transaction structure, and close with risk factors.
8. K8For a prospective client rather than an engaged seller, add the potential buyers and the rationale for each.
9. K9For a prospective client, also add the process and timeline plus the bank's transaction and deal credentials.

R1K1→K9requiresTest it

Bank credentials and process timeline only belong because the pitchbook is a marketing document courting a prospective client.

R2K2→K4requiresTest it

Valuation only lands if the strategic rationale already argued why a sale creates value now.

R3K3→K5precedesTest it

Projected financials presuppose the target's product, history, and strategy that the overview establishes.

R4K4→K5requiresTest it

Comparables and DCF can't produce an implied value without historical and projected financials feeding the multiples and cash flows.

R5K6↔K7confused withTest it

Accretion/dilution on likely buyers is easily stated as the seller's own transaction structure, conflating EPS impact with deal terms.

R6K8→K9applies withinTest it

Process timeline and credentials are added only within the same prospective-client condition that triggers the potential-buyers section.

1. K1A joint venture is a jointly owned entity or contractual arrangement in which two companies pursue a specific project while remaining independent
2. K2One reason is collaboration while each parent keeps its independence — a partnership without the merger or full integration that would dissolve separate corporate identities
3. K3Risk-sharing: the specific mechanism is that an expensive or uncertain project is placed in a separate vehicle, so losses and liabilities are allocated between the partners rather than sitting entirely on one company's balance sheet
4. K4Complementary capabilities: each partner contributes a specific capability the other lacks — for instance technology paired with distribution channels — so the venture combines resources that neither could supply internally
5. K5Market entry: a local partner supplies the specific geographic knowledge, relationships, or regulatory access required to operate in a new country, which the entering firm does not have
6. K6Resource pooling: partners contribute capital, assets, and personnel to a shared entity to reach a scale of funding, capacity, or operations that neither would finance or staff on its own
7. K7Strategic testing: a JV is a low-commitment way to trial a business or market before deciding to buy or build it fully, limiting exposure if the venture fails
8. K8Regulatory considerations: structuring cooperation as a JV allows the parties to fit within foreign ownership limits or clear antitrust hurdles that a full merger or acquisition would trigger
9. K9The through-line: a JV captures the benefits of cooperation without the cost, commitment, and irreversibility of a full acquisition

R1K3→K7precedesTest it

Strategic testing consumes the risk-shared vehicle idea: the trial's exposure is limited only by placing the experiment in the separate JV entity.

R2K4↔K6confused withTest it

Both describe combining partner contributions, so learners state resource pooling when the specific mechanism is complementary capability pairing.

R3K5→K8requiresTest it

Regulatory structuring only becomes a reason when foreign market entry presents ownership limits or antitrust hurdles to clear.

R4K9→K2causesTest it

The through-line states the JV's independence-preserving cooperation motive, which is what produces the first listed reason.

R5K9→K3causesTest it

The through-line's cost-and-commitment-limiting logic is the mechanism that makes risk-sharing a reason to choose a JV.

1. K1Synergies are value a combination creates that neither company could achieve alone, and they come in three types
2. K2Revenue synergies increase the combined top line by selling more than the two companies could separately, through cross-selling to each other's customers, geographic expansion, and new product lines
3. K3Cost synergies shrink the combined expense base by eliminating duplication across the two companies, through shared overhead, reduced duplicate headcount, and consolidated facilities
4. K4Financial synergies lower the cost of capital — the stronger combined balance sheet borrows on better terms, enabling cheaper financing for the merged entity
5. K5Revenue synergies require a specific cross-selling or market-expansion mechanism to be a real synergy rather than just a label
6. K6Cost synergies are more concrete and realized sooner, so they're more credible; revenue synergies often deserve a haircut in valuation

R1K1↔K4confused withTest it

Financial synergies (a type) are easily swapped with the general definition of synergies as value neither firm could achieve alone.

R2K5→K2requiresTest it

Revenue synergy's status as a real synergy depends on naming its mechanism, which is exactly the content of KLP 1.

R3K6→K3requiresTest it

Claiming cost synergies are more credible needs the prior result that they come from eliminating duplication, which is concrete and fast.

R4K6→K2applies withinTest it

The valuation haircut for revenue synergies only makes sense because revenue synergies are the less concrete category defined in KLP 1.

1. K1Governments block M&A transactions to enforce antitrust laws and prevent excessive market concentration that reduces competition.
2. K2National security and defense concerns can cause regulators to block M&A deals, particularly cross-border transactions.
3. K3Transactions may be deterred to ensure consumer protection against price gouging, lower quality, or limited choices.
4. K4Regulators intervene in M&A to mitigate systemic risk to the broader economy and prevent severe adverse labor market impacts.
5. K5Data privacy and cybersecurity risks arising from combined corporate datasets serve as valid grounds to block M&A deals.

No relations on this card. That is a real finding rather than a gap when the points are parallel — an enumeration has nothing to derive from anything else.

1. K1A divestiture is the sale of part of a company — a division, subsidiary, or product line — to another party.
2. K2A buyer with synergies may pay more for the unit than the market values it at inside the parent, so selling can capture value the public market was discounting.
3. K3Selling a unit delivers immediate cash proceeds to the parent, whereas holding it yields only future cash flows that are uncertain and already reflected in the share price.
4. K4With one fewer business, management time and capital concentrate on the core, and investors typically reward pure-play focus with a higher multiple.
5. K5Because the sale proceeds are cash rather than a claim on the whole company, the parent can fund growth, pay down debt, or buy back stock without issuing new shares.
6. K6Exiting a unit frees the capital tied up in it for redeployment into businesses the company judges more attractive.
7. K7Divesting a unit lets management stop funding a business whose strategic fit with the remaining company has weakened.
8. K8Selling a failing, low-margin, or capital-intensive division removes a drag on consolidated margins and returns on capital.
9. K9Divesting a division that no longer fits the parent's strategy simplifies the company into a more focused, easier-to-understand business.

R1K2↔K3confused withTest it

Both explain why selling beats holding: synergy premium versus immediate cash versus future cash flows.

R2K3→K5causesTest it

Cash proceeds are what enable funding growth, debt paydown, or buybacks without issuing shares.

R3K4↔K9confused withTest it

Both cite focus as the benefit — one as higher multiple from concentration, the other as simpler business.

R4K6↔K8confused withTest it

Both justify selling a unit — one by redeployment opportunity, the other by removing a weak performer.

R5K7→K9requiresTest it

Simplification into a focused business cannot hold unless management first identifies weakened strategic fit.

1. K1Strategic rationale means identifying an asset gap one company has that the other fills — e.g., Disney owns world-class IP but lacks in-house gaming capability.
2. K2The fit test is extension, not overlap: the target's capabilities must add something the buyer does not already have.
3. K3EA's game engines and live-services expertise constitute the capability Disney lacks in-house.
4. K4EA's distribution reach is a capability Disney does not already own.
5. K5Revenue synergies: owning the target lets the buyer monetize in-house what it currently licenses away, keeping the full economics of the IP.
6. K6Further revenue synergies include cross-selling subscriptions such as bundling EA Play with Disney+, plus joint marketing across franchises.
7. K7Cost synergies: eliminate the licensing fees the buyer pays third parties today, cut duplicate corporate overhead, and lower customer acquisition costs.
8. K8A strong answer specifies the integration challenges that must be managed for the deal to deliver its synergies — e.g., reconciling a game studio's development culture and production pipeline with a media buyer's existing operations.

R1K1→K3causesTest it

If the gap were not in gaming IP monetization, EA's engine and live-services fit would not follow.

R2K2→K1requiresTest it

Zeroing in on an asset gap is the positive test for fit that KLP1's extension rule installs.

R3K4→K2applies withinTest it

Calling EA's distribution a non-overlapping capability presupposes the extension test, not just any capability.

R4K7→K8causesTest it

If cost synergies did not require eliminating licensing fees and overhead, integration challenges would be materially lighter.

1. K1Raising the purchase price cuts EPS because a higher price means a larger debt draw or more shares issued.
2. K2Raising the purchase price also increases the intangible amortization recorded.
3. K3Lowering the revenue projections reduces combined net income dollar-for-dollar.
4. K4Decreasing the synergy estimates is the first place to look.
5. K5Synergy timing matters as well as size — pushing realization out further reduces the accretion shown in the projection window.
6. K6You can also raise the cost of financing by assuming a higher interest rate on the debt.
7. K7You can also raise the cost of financing by assuming a richer exchange ratio on the stock component.
8. K8Add integration and transaction costs or purchase-accounting amortization if the model left them out.
9. K9If the deal still looks accretive after conservative inputs, it may genuinely be accretive.

R1K1→K2causesTest it

A higher purchase price forces a larger debt draw or share issuance, which itself creates additional intangible amortization.

R2K2↔K8confused withTest it

Both raise EPS-dilutive amortization, but purchase-accounting amortization from a higher price is distinct from newly added deal costs.

R3K4→K5requiresTest it

Knowing synergy timing matters requires first identifying synergy size as the primary adjustment lever.

R4K6↔K7confused withTest it

Both raise financing cost, but a higher debt interest rate is mechanically different from a richer stock exchange ratio.

1. K1Dilution means pro forma EPS is lower than the buyer's standalone EPS, so the buyer attacks either the combined net income or the per-share cost of the deal.
2. K2Funding with cash on hand or low-cost debt is cheaper per dollar of acquired earnings than issuing stock, because forgone interest on cash or after-tax interest on debt is typically less than the earnings yield being acquired.
3. K3Editing the capital structure — refinancing existing debt at lower rates, extending maturities, or running the combined company with more leverage where cash flows support it — lowers the ongoing financing burden on EPS.
4. K4Negotiating a lower purchase price means less financing required, less dilution, and a smaller amortization drag on the combined income statement.
5. K5Structuring the deal consideration — for example, shifting the mix toward cash or debt and away from stock — avoids issuing the new shares that would enlarge the share count.
6. K6Structuring the deal to avoid or reduce incremental amortization of intangibles or write-ups raises the combined net income that feeds pro forma EPS.
7. K7Assuming and realizing more synergies raises combined net income — the numerator of EPS — directly lifting pro forma EPS.
8. K8Raising the target's standalone earnings forecast is another lever, since target net income flows straight into the numerator of pro forma EPS.

R1K1→K2requiresTest it

Picking cheaper funding per dollar of acquired earnings presupposes the dilution diagnosis that combined EPS falls below standalone EPS.

R2K4→K3precedesTest it

Quantifying the lower financing burden from refinancing requires knowing how much financing a lower purchase price eliminated.

R3K5→K1requiresTest it

Shifting consideration toward cash/debt avoids share-count growth only because dilution is defined by per-share, not aggregate, earnings.

R4K7↔K8confused withTest it

Both raise the EPS numerator, so learners conflate realizing combined synergies with raising the target's standalone earnings forecast.

1. K1A deal is accretive when the earnings yield you buy exceeds the cost of financing the purchase, and dilutive when it does not.
2. K2In an all-stock deal the financing cost is the acquirer's own earnings yield: every new share issued claims a slice of acquirer earnings at the acquirer's P/E, so issuing stock costs one over its P/E.
3. K3A higher-P/E target has a lower earnings yield, so each dollar of purchase price buys fewer dollars of target earnings.
4. K4The specific comparison that determines dilution is the target's earnings yield versus the acquirer's earnings yield: if the target's yield is lower, the deal is dilutive.
5. K5The acquirer issues shares carrying a high earnings yield and receives in exchange target earnings carrying a low one.
6. K6Example: an acquirer at 10x (10% yield) buying a 20x target (5% yield) issues $100 of stock that costs $10 of earnings support but delivers only $5 of earnings.
7. K7The shortfall between earnings given up and earnings gained is spread over the enlarged share count, so pro forma EPS falls.

R1K1→K4requiresTest it

The specific yield-comparison rule cannot stand unless dilution is defined as the earnings yield bought falling short of the financing cost.

R2K2→K3causesTest it

Only because issuing stock costs the acquirer's earnings yield does a higher-P/E target's lower yield mean the deal is dilutive.

R3K2↔K5confused withTest it

Both restate that stock issuance is priced at the acquirer's earnings yield, so learners assert one while crediting the other.

R4K3→K4causesTest it

The lower target earnings yield from a higher P/E only determines dilution when set against the acquirer's earnings yield.

R5K4→K7causesTest it

The yield comparison ruling the deal dilutive drives the earnings shortfall being spread over the enlarged share count, lowering pro forma EPS.

R6K4→K5requiresTest it

You cannot state which yield comparison determines dilution without first having the earnings given up and received in hand.

R7K5→K6applies withinTest it

The numerical illustration only holds within the framing of issuing high-yield shares for low-yield target earnings.

1. K1In a stock-for-stock deal, the deal currency is the buyer's own shares, so the buyer's valuation determines the effective price paid
2. K2When the buyer's shares are overvalued, each share issued carries more headline value than real value, so for a given headline purchase price the buyer parts with less real value than the target receives on paper
3. K3What matters is not the absolute fact that both companies are overvalued but the relative overvaluation of buyer versus target
4. K4Because overvaluation is not permanent, a buyer's multiple correcting before close, or before the target's does, can move the exchange-ratio economics against the buyer
5. K5If the buyer is more overvalued than the target, it pays with inflated currency and captures value from the target's shareholders
6. K6When the buyer is more overvalued than the target, the deal is cheap financing, not a problem
7. K7The risky case is an overvalued buyer that is less overvalued than the target, or an undervalued buyer using stock: it issues more shares than the real value transferred justifies and overpays in economic terms

R1K3→K5requiresTest it

You cannot claim the buyer captures value without first establishing that the relevant comparison is buyer-versus-target relative overvaluation, not absolute overvaluation.

R2K3→K7requiresTest it

Identifying the risky case as buyer less overvalued than target presupposes that what matters is the relative overvaluation, not the absolute fact.

R3K5→K6causesTest it

In the counterfactual world where the buyer is not more overvalued, the cheap-financing conclusion collapses and the deal becomes a problem.

1. K1Synergy distribution is the split of value created by the combination between the seller's and the buyer's shareholders
2. K2The acquisition premium — the price paid above the target's standalone value — is how the seller captures its share of the synergies
3. K3The buyer does not receive the portion of the synergy benefit paid out as premium
4. K4Both the seller and the buyer share the synergies, so the buyer acquires the target above standalone value rather than at standalone value
5. K5Sellers typically capture 25-50% of expected synergy value through the premium
6. K6The buyer retains the remainder — synergies realized post-close in excess of the premium paid — as incremental value
7. K7Bankers compare the premium paid to the present value of the synergies to advise the client on whether the deal creates value
8. K8If the premium exceeds the PV of synergies the buyer overpaid and destroyed value; below it, the buyer keeps positive value

R1K1→K2causesTest it

Framing synergy split as value shared between both shareholder groups is what makes the premium the seller's capture tool.

R2K2→K4causesTest it

The premium mechanism is what forces the buyer to pay above standalone value rather than at it.

R3K2↔K5confused withTest it

The empirical 25-50% range is easily swapped for the definitional premium-as-capture mechanism itself.

R4K3→K6requiresTest it

Buyer cannot retain post-close excess over premium without the premium subtracting exactly that portion.

R5K3↔K8confused withTest it

Buyer-not-receiving-premium portion is mistaken for buyer-overpaid-when-premium-exceeds-PV verdict.

R6K5→K6causesTest it

The 25-50% seller split mechanically fixes what remains as the buyer's share.

R7K7→K8requiresTest it

The overpayment verdict needs the premium-versus-synergy-PV comparison bankers perform.

R8K7→K8precedesTest it

You cannot derive whether the buyer overpaid without first having the premium-to-PV comparison result.

1. K1A fairness opinion is a letter from an independent financial advisor to a company's board on whether the transaction is fair from a financial point of view.
2. K2The board uses the fairness opinion to support its recommendation to shareholders and to satisfy its fiduciary duty not to mislead them.
3. K3It provides the board meaningful protection against shareholder litigation over the price.
4. K4The word independent matters: the advisor must be free of conflicts so the valuation of the target is genuinely unbiased.
5. K5A fairness opinion contains a range of valuations of the target based on the analyses performed, typically DCF, trading comparables, and precedent transactions, and presents the valuation as a range rather than a single number.
6. K6A fairness opinion contains the assumptions, limitations, and qualifications of the analyses — what the advisor relied on, what was excluded, and where the analysis could be wrong.
7. K7A fairness opinion ends with the advisor's explicit conclusion on whether the price or consideration is fair from a financial point of view.

R1K2→K3causesTest it

The litigation shield exists because the board uses the opinion to back its recommendation and discharge its fiduciary duty, so removing that use removes the protection.

R2K4→K1requiresTest it

An advisory letter from a conflicted advisor is not a genuine fairness opinion, so independence is constitutive of the letter itself.

R3K5→K7precedesTest it

The fairness conclusion must be anchored to the valuation range; without the range in hand, 'fair' has no referent.

R4K5↔K6confused withTest it

Learners conflate the valuation range itself with the caveats and exclusions that qualify that range.

R5K6→K7precedesTest it

The explicit fairness conclusion only counts as supported after the stated assumptions, limitations, and exclusions are laid out first.

1. K1A merger model combines the acquirer's and target's projected financial statements to measure the deal's impact on the acquirer's EPS.
2. K2Step one is projecting each company's income statement separately to establish standalone net income and standalone EPS as the baseline.
3. K3Step two is determining the purchase price and financing mix.
4. K4Cash used from the balance sheet costs the acquirer the interest income it would otherwise have earned on that cash.
5. K5New acquisition debt adds after-tax interest expense equal to the coupon times one minus the tax rate.
6. K6Stock consideration increases diluted shares by the value of stock issued divided by the acquirer's share price.
7. K7Pro forma net income combines the acquirer's and target's net income, plus synergies, less incremental amortization and one-time transaction costs, after financing adjustments.
8. K8Pro forma EPS equals pro forma net income divided by the new diluted share count, which combines the acquirer's standalone shares with any shares issued as consideration.
9. K9The deal is accretive if pro forma EPS exceeds standalone EPS, dilutive if it is lower — and you quote the accretion/dilution percentage.

R1K2→K8precedesTest it

The new diluted share count cannot be computed without standalone EPS, since only the standalone EPS tells you how many shares the acquirer has.

R2K3→K6requiresTest it

Without fixing the financing mix, there is no way to know what portion of consideration is stock and thus no share count.

R3K4→K7causesTest it

Foregone interest income on cash used is a direct reduction to pro forma net income, so the cash-financing premise drives the net income adjustment.

R4K4↔K5confused withTest it

Both are financing costs reducing pro forma income, one from using cash and one from issuing debt, so learners conflate them.

R5K7→K8causesTest it

Pro forma EPS is mechanically pro forma net income over new shares, so changing the net income adjustments changes the EPS numerator.

R6K8→K9precedesTest it

The accretion/dilution verdict is a comparison requiring the pro forma EPS result in hand before it can be stated.

1. K1Timing an M&A decision means judging whether the conditions that determine deal value and feasibility are better now or likely to be better in six months.
2. K2Market conditions: whether current valuation multiples are favorable and whether they could change over the next six months.
3. K3Interest rate environment: financing costs may rise or fall, changing the cost of a debt-funded deal.
4. K4Regulatory landscape: antitrust or industry regulation could shift and block or complicate the deal later.
5. K5Competitive dynamics: other buyers looking at the target can bid up the price or win it if you wait.
6. K6Target's trajectory: a well-performing target's valuation is likely to rise, so waiting may cost more.
7. K7Integration readiness: the acquirer needs management bandwidth to integrate, and rushing destroys value.
8. K8Stock price: if paying with stock, a depressed acquirer share price means issuing more shares per dollar of consideration.
9. K9Strategic urgency: how critical the deal is to the strategic plan can force acting now despite worse conditions.

R1K2→K8applies withinTest it

Stock-price dilution only matters if the acquirer pays in stock, which the valuation-multiple condition governs.

R2K2↔K6confused withTest it

Both concern valuation direction over six months, but one is market-wide multiples and one is target-specific performance.

R3K3→K8causesTest it

Rising rates raise the cost of debt, pushing acquirers toward stock, which makes share dilution newly salient.

R4K5→K6causesTest it

If competitors are circling the target, that competitive pressure directly accelerates the target's valuation trajectory.

R5K7↔K9confused withTest it

Both are internal 'act now' pressures, so a learner may cite integration bandwidth when strategy urgency is meant.